2026 TBICoE Annual Brain Health Symposium
Join the Traumatic Brain Injury Center of Excellence for the 2026 Annual Brain Health Symposium, a dynamic, full-day virtual event bringing together leaders in military medicine, neuroscience, and rehabilitation to explore the latest advances in brain health and TBI care. This year’s symposium will showcase groundbreaking work across the DoW and beyond, from the development of the Warfighter Brain Health Initiative 2.0 to innovative research on sleep, recovery, and family involvement in TBI outcomes. Experts will share insights on how policy, science, and lived experience come together to strengthen readiness and improve outcomes for service members and their families. This event is designed for clinicians, researchers, service members, and anyone dedicated to improving brain health in military and veteran communities. Attendees will walk away with valuable knowledge and practical insights to support TBI treatment and recovery.
Target Audience
This activity provides continuing education for physicians, nurses, physician associates/physician assistants, social workers, psychologists, athletic trainers, occupational therapists, occupational therapy assistants, physical therapists, and physical therapist assistants. A certificate of attendance is available for other attendees.
Learning Objectives
- Summarize the scope and activities that support the Department of War’s (DoW) Warfighter Brain Health Initiative (WBHI).
- Explain the main reasons why the WBHI is being refreshed.
- Outline how examples of how the WBHI is evolving from version 1.0 to version 2.0.
- Explain the neurobiology of sleep regulation and its implication on the management of TBI.
- Analyze the impact of TBI on sleep patterns and the evidence linking these sleep disturbances to an increased risk of dementia.
- Describe various biomarker and therapeutic approaches for managing sleep disturbances in patients with TBI.
- Describe the operational need for rapid, objective readiness screening tools in military and austere environments following suspected traumatic brain injury.
- Identify the methodology behind the development of the Battlefield Rapid Readiness Screening Guidelines.
- Summarize the key recommendations and thresholds of the Battlefield Rapid Readiness Screen.
- Describe the rationale for using adaptable sub-symptomatic exercise to treat persistent post-concussive symptoms in active-duty service members.
- Explain the design, methodology, and assessment battery used in the randomized controlled trial comparing ASSET, or Adaptable Sub-symptomatic Exercise Treatment, to a low-impact stretch/mobility program.
- Interpret the findings from the trial and determine how they might inform future clinical practice and research on concussion rehabilitation.
- Explain the relevance of Post-Traumatic Stress Disorder (PTSD) in Traumatic Brain Injury (TBI) outcomes.
- Describe a paradigm shift in TBI research towards a holistic perspective of brain health.
- Identify methods of data capture that go beyond symptoms.
- Describe the bidirectional impact of invisible wounds including mild traumatic brain injury (mTBI) on family dynamics in military populations.
- Identify barriers to family engagement in the treatment of mTBI and invisible wounds.
- Infer key aspects of patient/caregiver experience of mTBI.
- Summarize potential solutions and approaches for supporting military families affected by traumatic brain injury (TBI) and invisible wounds.
Kathy Lee, MS, ARNP. Presenter has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
CDR J. Kent Werner, MD, PhD. Presenter has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
LTC Bradley A. Dengler, MD, FAANS, FACS. Presenter has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
Andrew J. Darr, PhD. Presenter has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
Ida Babakhanyan, PhD. Presenter has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
Susan Gallardo, LCSW, CBIS. Presenter has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
Disclosure: DHA J-7 staff, planners, authors, faculty, and content reviewers for this educational activity have no relevant financial or non-financial relationship(s) with ineligible companies to disclose.
Available Credit
- 6.00 AAPA
DHA J-7 CEPO has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.00 hours of AAPA Category 1 CME credits. Approval is valid until Wednesday, April 1, 2026 - 11:59pm ET. PAs should only claim credit commensurate with the extent of their participation.
- 6.00 ACCME Non-Physician CME Credit
DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 6.00 hours for completing this Course activity.
- 6.00 AMA PRA Category 1 Credit™
DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DHA, J-7, CEPO designated this Course for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 6.00 ANCC
DHA, J-7, CEPO is accredited by the Joint Accreditation/ Interprofessional Continuing Education (IPCE) to provide this Continuing Nursing Education Course for a maximum of 6.00 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
- 6.00 AOTA
DHA, J-7, CEPO is an American Occupational Therapy Association (AOTA) Approved Provider of professional development (PD). PD activity approval ID# 15716. This Live course is offered at 0.6 CEUs, . AOTA does not endorse specific course content, products, or clinical procedures.
- 6.00 APA
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. Participants may earn 6.00 CE credits for completing this activity.
- 6.00 APTA
DHA, J-7, CEPO is an American Physical Therapy Association (APTA) Approved Provider of continuing education. This activity was planned by and for the health care team, and learners will receive 0.6 APTA CEUs. The assignment of APTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by APTA. APTA CEUs are accepted by most state PT licensing boards. Learners are encouraged to check with their local chapter or state board to ensure that they accept APTA accredited courses for licensure renewal.
- 6.00 ASWB
As a Jointly Accredited Organization, DHA, J7, CEPO is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 6.00 General continuing education credits.
- 6.00 Attendance
- 6.00 BOC
Board of Certification for the Athletic Trainer (BOC)
DHA, J-7, CEPO (BOC AP #:JA4008136) is approved by the Board of Certification, Inc., to provide continuing education to Athletic Trainers (ATs). This program is eligible for a maximum of 6.00 Category A hours/Continuing Education Units (CEUs). ATs should claim only those hours actually spent in the educational program
- 6.00 IPCE
In support of improving patient care, DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the healthcare team, and learners will receive 6.00 Interprofessional Continuing Education (IPCE) credits for learning and change.
Requirements: CE/CME certificates are awarded to participants who fully complete the activity, successfully submit the evaluation survey, and pass the posttest. The deadline to claim credit is Apr 1, 2026.
Access Code: Some activities require an access code to register or claim credit. Please contact the organization providing the activity for the access code. The Continuing Education Program Office (CEPO) does not provide access codes.
Accommodations: Please contact the course instructor to inquire about accommodations. For additional accommodation requests and/or technical support, email [email protected].

Facebook
Twitter
LinkedIn
Forward
Facebook
X
LinkedIn
Forward